Editorial: Recent advances in oncolytic virus therapy for brain tumors.

Autor:	Askari FS; Department of Microbiology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.; Vista Aria Rena Gene Inc., Gorgan, Golestan, Iran., Mohebbi A; Vista Aria Rena Gene Inc., Gorgan, Golestan, Iran.; Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran., Ning J; Department of Neurosurgery, University of Minnesota, Minneapolis, MN, United States., Kurozumi K; Department of Neurosurgery, Hamamatsu Medical University, Shizuoka, Japan., Wakimoto H; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.
Jazyk:	angličtina
Zdroj:	Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2023 Aug 17; Vol. 13, pp. 1271559. Date of Electronic Publication: 2023 Aug 17 (Print Publication: 2023).
DOI:	10.3389/fcimb.2023.1271559
Abstrakt:	Competing Interests: Authors AM and FSA are affiliated with Vista Aria Rena Gene Inc., Iran. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu